|
SLC35E1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.154400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.058970E-01 |
| Normal-vs-Stage2 |
7.489800E-01 |
| Normal-vs-Stage3 |
4.185800E-01 |
| Normal-vs-Stage4 |
6.982800E-01 |
| Stage1-vs-Stage2 |
6.070200E-01 |
| Stage1-vs-Stage3 |
7.230200E-02 |
| Stage1-vs-Stage4 |
4.460200E-01 |
| Stage2-vs-Stage3 |
4.049400E-01 |
| Stage2-vs-Stage4 |
6.202000E-01 |
| Stage3-vs-Stage4 |
9.849200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.792400E-01 |
| Normal-vs-AfricanAmerican |
9.865800E-01 |
| Normal-vs-Asian |
6.791800E-01 |
| Caucasian-vs-AfricanAmerican |
6.384800E-01 |
| Caucasian-vs-Asian |
8.094400E-01 |
| AfricanAmerican-vs-Asian |
6.894000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.196820E-01 |
| Normal-vs-Female |
6.866300E-02 |
| Male-vs-Female |
4.921800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.223800E-01 |
| Normal-vs-Extreme_Weight |
2.967500E-02 |
| Normal-vs-Obese |
1.816020E-01 |
| Normal-vs-Extreme_Obese |
9.803600E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.983200E-01 |
| Normal_Weight-vs-Obese |
5.014400E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.831200E-01 |
| Extreme_Weight-vs-Obese |
6.317600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.668200E-01 |
| Obese-vs-Extreme_Obese |
8.693800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.479600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.332400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.678000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.599200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.326250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.756100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.518400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.604430E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.899800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.961030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.607800E-01 |
| Normal-VS-Type2 PRCC |
1.134440E-01 |
| Normal-VS-KIRP CIMP |
5.854300E-02 |
| Normal-VS-Unclassified PRCC |
3.141800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.979400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.226000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.880000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.261700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.290500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.964400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.932160E-01 |
| Normal-vs-N1 |
3.724600E-01 |
| Normal-vs-N2 |
5.534600E-01 |
| N0-vs-N1 |
1.406050E-01 |
| N0-vs-N2 |
4.484000E-01 |
| N1-vs-N2 |
6.237000E-01 |
|
|
